221 related articles for article (PubMed ID: 29474539)
1. miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate-Activated Protein Kinase α1 in Male Mice.
Chen T; Yan D; Cheng X; Ji X; Bian J; Yin W
Endocrinology; 2018 May; 159(5):2008-2021. PubMed ID: 29474539
[TBL] [Abstract][Full Text] [Related]
2. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
[TBL] [Abstract][Full Text] [Related]
3. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase.
Liao CC; Ou TT; Huang HP; Wang CJ
J Sci Food Agric; 2014 Apr; 94(6):1154-62. PubMed ID: 24027117
[TBL] [Abstract][Full Text] [Related]
6. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.
Liu XL; Cao HX; Wang BC; Xin FZ; Zhang RN; Zhou D; Yang RX; Zhao ZH; Pan Q; Fan JG
World J Gastroenterol; 2017 Dec; 23(46):8140-8151. PubMed ID: 29290651
[TBL] [Abstract][Full Text] [Related]
7. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
8. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1.
Guo Y; Yu J; Wang C; Li K; Liu B; Du Y; Xiao F; Chen S; Guo F
J Mol Endocrinol; 2017 Oct; 59(3):205-217. PubMed ID: 28667176
[TBL] [Abstract][Full Text] [Related]
9. Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets.
Son Y; Jang MK; Jung MH
J Med Food; 2014 Dec; 17(12):1322-31. PubMed ID: 25357150
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
Zhang M; Sun W; Zhou M; Tang Y
Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
[TBL] [Abstract][Full Text] [Related]
11. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
12. Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.
Chen X; Tan QQ; Tan XR; Li SJ; Zhang XX
Cell Death Dis; 2021 Aug; 12(9):809. PubMed ID: 34446693
[TBL] [Abstract][Full Text] [Related]
13. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
[TBL] [Abstract][Full Text] [Related]
14. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.
Chen S; Chen D; Yang H; Wang X; Wang J; Xu C
BMC Gastroenterol; 2020 Feb; 20(1):39. PubMed ID: 32070295
[TBL] [Abstract][Full Text] [Related]
15. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
17. Involvement of adenosine monophosphate-activated protein kinase in the influence of timed high-fat evening diet on the hepatic clock and lipogenic gene expression in mice.
Huang Y; Zhu Z; Xie M; Xue J
Nutr Res; 2015 Sep; 35(9):792-9. PubMed ID: 26239949
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
[TBL] [Abstract][Full Text] [Related]
19. miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
Wang YD; Wu LL; Mai YN; Wang K; Tang Y; Wang QY; Li JY; Jiang LY; Liao ZZ; Hu C; Wang YY; Liu JJ; Liu JH; Xiao XH
Metabolism; 2023 Sep; 146():155660. PubMed ID: 37451670
[TBL] [Abstract][Full Text] [Related]
20. Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes.
Min KH; Yang WM; Lee W
Biochem Biophys Res Commun; 2018 Sep; 503(3):1587-1593. PubMed ID: 30033101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
